Pharmabiz7h
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Pharmabiz7h
WCG introduces ClinSphere Total Enrollment: An all-new participant recruitment and retention SaaS solution for clinical trials
An all-new participant recruitment and retention SaaS solution for clinical trials: Princeton, New Jersey Tuesday, January 28, 2025, 18 ...
Pharmabiz8h
ManipalCigna Health Insurance drives awareness with free health checkup camps
ManipalCigna Health Insurance drives awareness with free health checkup camps: Our Bureau, Bengaluru Tuesday, January 28, 2025, 17:15 Hrs [IST] ManipalCigna Health Insurance in co ...
Pharmabiz8h
Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders
Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:45 Hrs [IST] Global pharma major Lupin Lim ...
Pharmabiz9h
Confluence of modern medicine and technology discussed at PIWOT-2025 in Mumbai
Confluence of modern medicine and technology discussed at PIWOT-2025 in Mumbai: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:15 Hrs [IST] Leading experts from healthcare, medi ...
Pharmabiz8h
Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent
Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent: New York Tuesday, January 28, 2025, 17:00 Hrs [IST] Anavex Life Sciences Corp., a clin ...
Pharmabiz17h
ICMR invites EoI for development of point-of-care serum ferritin device to diagnose iron deficiency
ICMR invites EoI for development of point-of-care serum ferritin device to diagnose iron deficiency: Shardul Nautiyal, Mumbai Tuesday, January 28, 2025, 08:00 Hrs [IST] The Indian ...
Pharmabiz14h
Roche announces positive results from EMBARK phase III study of Elevidys in ambulatory individuals with DMD
Roche announces positive results from EMBARK phase III study of Elevidys in ambulatory individuals with DMD: Basel Tuesday, January 28, 2025, 11:00 Hrs [IST] Roche announced posit ...
Pharmabiz16h
AHPI to host intl. conclave on 'Patient-Centred Care: Revolutionizing Hospital Management' in Kochi on Jan 31 & Feb 1
Revolutionizing Hospital Management' in Kochi on Jan 31 & Feb 1: Our Bureau, Bengaluru Tuesday, January 28, 2025, 09:00 Hrs [ ...
Pharmabiz15h
US FDA grants priority review status to Merck’s sNDA for Welireg to treat patients with advanced pheochromocytoma and paraganglioma
Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...
Pharmabiz14h
Dr Agarwal’s Health Care’s IPO to open on January 29, price band set at Rs. 382 to Rs. 402 per equity share
Dr Agarwal’s Health Care’s IPO to open on January 29, price band set at Rs. 382 to Rs. 402 per equity share: Our Bureau, Mumbai Tuesday, January 28, 2025, 10:45 Hrs [IST] Dr A ...
Pharmabiz13h
Siemens Healthineers underscores need for informed clinical decision making in medical care with launch of novel equipment at AOCR 2025
Siemens Healthineers underscores need for informed clinical decision making in medical care with launch of novel equipment at AOCR 2025: Our Bureau, Bengaluru Tuesday, January 28, ...